Port Philip publishing sent me this just now:
ASX listed company ResApp Health [ASX:RAP] is developing the kind of product that does just that. Its mobile phone app can detect a range of lung diseases through analysing the sounds of a cough.
It’s part of the growing field of m-Health (mobile health) that is estimated to be a US$100 billion industry by 2022 according to some research.
